Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02568501 · ClinicalTrials.gov registry record · Phase 3
Behavioral Economic Incentives to Improve Glycemic Control Among Adolescents and Young Adults
A Phase 3 study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 3
- Development phase
- 90
- Enrollment target
NCT02568501: Completed Phase 3 study, sponsored by University of Pennsylvania.
NCT02568501 is a Phase 3 study that has completed, run by University of Pennsylvania. The registered enrollment target is 90 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02568501, a Phase 3 study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 90 participants
- Enrollment target
Study Summary
In this study the investigators will compare a novel approach using daily financial incentives and a tiered sponsor network to motivate adolescents and young adults with type 1 diabetes to improve glycemic control.
Primary Outcome
Change in HbA1c from baseline to 3 months
Interventions
- BEHAVIORAL Financial incentive
- BEHAVIORAL Daily feedback
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2016-01 |
| Est. Completion | 2016-11 |
| Phase | Phase 3 |
What the finished NCT02568501 record still lists
NCT02568501 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 2 interventions - of which Financial incentive is the first listed.
NCT02568501 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02568501 about?
NCT02568501 is a clinical study titled "Behavioral Economic Incentives to Improve Glycemic Control Among Adolescents and Young Adults". In this study the investigators will compare a novel approach using daily financial incentives and a tiered sponsor network to motivate adolescents and young adults with type 1 diabetes to improve glycemic control.
What is the current status of trial NCT02568501?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 90 participants. The study started on 2016-01. Estimated completion is 2016-11.
What interventions are being tested in trial NCT02568501?
The interventions under investigation include: Financial incentive (BEHAVIORAL), Daily feedback (BEHAVIORAL).
Who is sponsoring clinical trial NCT02568501?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02568501's enrollment target sits among peer trials
90 1724th of 2000 higher than 263 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia